Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
about
Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's diseaseGastroprotective action of glucocorticoid hormones during NSAID treatmentMolecular and pharmacological evidence for modulation of kinin B(1) receptor expression by endogenous glucocorticoids hormones in ratsDual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitorsDifferential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.Glucocorticoid-attenuated response genes induced in the lung during endotoxemia.Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.Prostaglandin endoperoxide synthetase isoenzymes: the clinical relevance of selective inhibition4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2).Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines.Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline resultsCyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.The development of COX2 inhibitors.Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide.A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model.Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.The mechanism of the inhibitory effect of polyamines on the induction of nitric oxide synthase: role of aldehyde metabolites.Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury.Caloric restriction as a mechanism mediating resistance to environmental diseaseDown-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1.The regulation of muscle mass by endogenous glucocorticoids.Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment.Low-level laser therapy (LLLT) reduces the COX-2 mRNA expression in both subplantar and total brain tissues in the model of peripheral inflammation induced by administration of carrageenan.Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapyNon-steroidal anti-inflammatory drugs and colorectal cancer preventionProstaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease.Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia.Nitric oxide synthase-cyclo-oxygenase pathways in organum vasculosum laminae terminalis: possible role in pyrogenic fever in rabbits.Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.Agents in development for prostate cancer prevention.Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes.Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis.Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical site-restricted cytokine-target cell interactions.Impact of maternal dexamethasone on coronary PGE(2) production and prostaglandin-dependent coronary reactivity.Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo
P2860
Q28175939-4375A33C-3B30-4937-8CD9-39E1D592B5E2Q28193027-BC0C05E6-8737-405E-AF80-16C721A949B2Q28346431-FDD0945E-AE13-49EB-81C6-92C387AB4A3EQ28367719-CF6FD65C-4FEC-4AEB-BA54-001BDA931350Q30428613-8D87A9A7-1886-4DE3-AE5C-A0A1F62867BCQ30841886-172E6821-86FF-41AC-BD56-8E5B5941D223Q32045021-2C959C9A-7991-4100-8EDD-0A00FDC46649Q33578551-DE3AA330-D2D4-407E-864D-EA2DF976FA62Q33610651-3E5859D3-CFDA-4425-B0E7-B6CD2293ED33Q33754989-38C52F3A-C4F2-4897-B01E-C2AFE971E60AQ33801163-DF35C57B-426E-4825-B703-F77F716F01C1Q33836869-E402CAC7-9310-4F11-AE54-FF066AAA5F02Q34132261-E1E76CA7-CBEE-48A8-BFC6-6AC684C1FD04Q34180681-73B1FD5F-45B3-4789-88BF-97CFA37415CBQ34201538-C3C0531B-950A-4BEC-9A49-440C7139BFFDQ34205440-456950E5-0B37-44A7-8587-9846E9E65F75Q34211740-930B5CCA-FFF3-498F-9C61-FD214319A726Q34793507-B2AD8B8D-3537-462E-BDB9-1BADD114DE74Q34806489-78C38256-A613-48C4-9A30-34E85D41D43BQ34940547-1AAE062B-E3EB-45F4-B9F8-7552B519563DQ35028587-FFA74B53-E8E1-4421-8672-B1F96F8D9752Q35042169-654FD59A-8EDF-40F5-AFBD-11E1B3B3C63CQ35043366-D7195F20-F924-47A5-BA1D-A8BD29272A64Q35095129-1B7BF460-82D6-4ED6-8908-9A57530D6418Q35163045-EF319B99-270A-425B-A04B-D48B76A5B929Q35373624-771DD76F-1BB4-4C77-B72F-DD0CC2D882E1Q35521719-69CCCD0D-B487-44A9-AEBC-0A1C21496744Q35543612-5A7750FA-7925-49F8-B3CD-9CF4832F7AADQ35621619-E620D9FD-80F2-4D29-8B8E-F9F64A87CD1DQ35824725-DBCF6E2C-2D17-44AE-B659-13795BD9F6B6Q35872603-5B97CCFB-9C7D-45FB-8474-174D83279DE9Q35873527-C03B19C3-7384-41BD-9CF3-D2C5B8791BC4Q35953747-80729844-3B62-4621-92AF-FA35649AD203Q35964705-BB0DA478-7EDC-48BE-BAB4-0630B7555928Q36012290-6BB7B177-405A-4EF3-96CE-1A4C37F7CD4DQ36033294-79F230CA-AC13-4367-83A3-E41E3E3D43BDQ36052673-DECB287F-F5E1-4657-8EDC-D0EF4DED37A8Q36226582-FDE143BA-A42C-4FA2-84EB-D336AB0BDF83Q36309144-67AA802D-10A5-419F-9AF3-A68175FC8DBDQ36329559-E5A9BE89-2752-4F2D-96E8-0496F50121B0
P2860
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
@en
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
@nl
type
label
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
@en
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
@nl
prefLabel
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
@en
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
@nl
P2093
P2860
P356
P1476
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
@en
P2093
Masferrer JL
Needleman P
P2860
P304
P356
10.1073/PNAS.89.9.3917
P407
P577
1992-05-01T00:00:00Z